BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25271250)

  • 1. Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism.
    Indra T; Holaj R; Štrauch B; Rosa J; Petrák O; Šomlóová Z; Widimský J
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1109-17. PubMed ID: 25271250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
    Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
    Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.
    Catena C; Colussi GL; Marzano L; Sechi LA
    Horm Metab Res; 2012 Mar; 44(3):188-93. PubMed ID: 22351477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.
    Rossi GP; Cesari M; Cuspidi C; Maiolino G; Cicala MV; Bisogni V; Mantero F; Pessina AC
    Hypertension; 2013 Jul; 62(1):62-9. PubMed ID: 23648698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.
    Ori Y; Chagnac A; Korzets A; Zingerman B; Herman-Edelstein M; Bergman M; Gafter U; Salman H
    Nephrol Dial Transplant; 2013 Jul; 28(7):1787-93. PubMed ID: 23378418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score-Matching Follow-Up Study With Tissue Doppler Imaging.
    Chang YY; Liao CW; Tsai CH; Chen CW; Pan CT; Chen ZW; Chen YL; Lin LC; Chang YR; Wu VC; Wu KD; Hung CS; Lin YH; ;
    J Am Heart Assoc; 2019 Nov; 8(22):e013263. PubMed ID: 31718437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness.
    Holaj R; Rosa J; Zelinka T; Štrauch B; Petrák O; Indra T; Šomlóová Z; Michalský D; Novák K; Wichterle D; Widimský J
    J Hypertens; 2015 Apr; 33(4):874-82; discussion 882. PubMed ID: 25490707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Salt Intake Is a Determinant of Cardiac Changes After Treatment of Primary Aldosteronism: A Prospective Study.
    Catena C; Colussi G; Novello M; Verheyen ND; Bertin N; Pilz S; Tomaschitz A; Sechi LA
    Hypertension; 2016 Jul; 68(1):204-12. PubMed ID: 27245179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy.
    Lin YH; Lee HH; Liu KL; Lee JK; Shih SR; Chueh SC; Lin WC; Lin LC; Lin LY; Chung SD; Wu VC; Kuo CC; Ho YL; Chen MF; Wu KD;
    Surgery; 2011 Sep; 150(3):526-33. PubMed ID: 21514614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma.
    Zarnegar R; Lee J; Brunaud L; Lindsay S; Kebebew E; Clark OH; Duh QY
    Surgery; 2007 Dec; 142(6):921-9; discussion 921-9. PubMed ID: 18063077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy.
    Lin YH; Huang KH; Lee JK; Wang SM; Yen RF; Wu VC; Chung SD; Liu KL; Chueh SC; Lin LY; Ho YL; Chen MF; Wu KD;
    J Renin Angiotensin Aldosterone Syst; 2011 Mar; 12(1):48-53. PubMed ID: 20719880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of surgical and conservative treatment of patients with primary aldosteronism.
    Horký K; Widimský J; Hradec E; Gregorová I; Hradec M
    Exp Clin Endocrinol; 1987 Dec; 90(3):337-46. PubMed ID: 3450533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Left ventricular myocardial structure and function in patients with primary aldosteronism].
    Arabidze GG; Chikhladze NM; Sergakova LM; Iarovaia EB
    Ter Arkh; 1999; 71(9):13-9. PubMed ID: 10553618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D; Rumboldt Z; Bagatin J; Polić S
    Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies.
    Marzano L; Colussi G; Sechi LA; Catena C
    Am J Hypertens; 2015 Mar; 28(3):312-8. PubMed ID: 25336498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular repolarization before and after treatment in patients with secondary hypertension due to renal-artery stenosis and primary aldosteronism.
    Maule S; Bertello C; Rabbia F; Milan A; Mulatero P; Milazzo V; Papotti G; Veglio F
    Hypertens Res; 2011 Oct; 34(10):1078-81. PubMed ID: 21677661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
    De Simone R; Irace L; Perna B; Caruso C; Guida M; Iacono A
    Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
    Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
    Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.